Search Results

The Bioscience Association Manitoba (BAM) is pleased to announce the appointment of Andrea Ladouceur as its new President.

Kane Biotech Inc. announces that at the Bioscience Association of Manitoba annual awards dinner held on March 7, 2024, Kane Biotech received the BAM Company of the Year award.

Bioscience Association Manitoba has announced its participation at BIO International Convention, taking place from June 5-8, 2023, at the Boston Convention & Exhibition Center.

Mitsubishi Tanabe Pharma Canada, a subsidiary of Mitsubishi Tanabe Pharma America, Inc., announced that effective December 21, 2023, the Manitoba Pharmacare Program will cover RADICAVA® Oral Suspension for the treatment of people living with amyotrophic lateral sclerosis, a rapidly progressive, neurodegenerative disease.1

Today marks the beginning of Global Biotech Week which aims to increase awareness of Manitoba’s $10.4 billion biotech industry, its global potential, policymakers, influencers, and the public.

Valeo Pharma Inc., a Canadian pharmaceutical company, is proud to announce another major milestone for its two innovative Asthma therapies; Enerzair Breezehaler and Atectura Breezhaler, which have been accepted for reimbursement by the Ontario Drug Benefit program, the Manitoba Pharmacare Program, the New Brunswick Drug plan, and the NIHB and VAC federal programs.

On Saturday June 8, 2019 in Winnipeg, Maxim Truck & Trailer had a team of 68 walkers and volunteers who raised $230,024 for CancerCare Manitoba’s 2019 Challenge for Life event.

Dexcom, Inc., a global leader in real-time continuous glucose monitoring, is happy to share that people with type 1 diabetes who are 25 years of age or under may now be eligible for provincial coverage of the Dexcom G6 CGM System through Manitoba Health and Seniors Care.